Assembly Biosciences Analyst Ratings
Assembly Biosciences Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/16/2022 | 115.83% | Mizuho | $14 → $3 | Maintains | Buy |
| 10/24/2022 | 43.88% | Truist Securities | $11 → $2 | Downgrades | Buy → Hold |
| 04/01/2022 | 763.31% | Truist Securities | $15 → $12 | Maintains | Buy |
| 09/13/2021 | 151.8% | HC Wainwright & Co. | → $3.5 | Initiates Coverage On | → Neutral |
| 09/02/2021 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 05/10/2021 | 403.6% | SVB Leerink | $8 → $7 | Maintains | Market Perform |
| 03/23/2021 | 475.54% | SVB Leerink | $9 → $8 | Downgrades | Outperform → Market Perform |
| 11/06/2020 | 619.42% | Jefferies | → $10 | Downgrades | Buy → Hold |
| 10/19/2020 | 3856.83% | Truist Securities | → $55 | Initiates Coverage On | → Buy |
| 07/08/2020 | 2633.81% | SVB Leerink | $36 → $38 | Maintains | Outperform |
| 10/16/2019 | 1338.85% | Mizuho | → $20 | Initiates Coverage On | → Buy |
| 10/08/2018 | 2921.58% | B. Riley Securities | $42 → $42 | Upgrades | Neutral → Buy |
| 08/08/2018 | 5223.74% | Baird | → $74 | Initiates Coverage On | → Outperform |
| 05/08/2018 | 2921.58% | B. Riley Securities | $45 → $42 | Maintains | Neutral |
| 04/13/2018 | — | Chardan Capital | Downgrades | Buy → Neutral | |
| 01/05/2018 | 2417.99% | B. Riley Securities | → $35 | Initiates Coverage On | → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 11/16/2022 | 115.83% | 瑞穗 | $14 → $3 | 维护 | 买 |
| 10/24/2022 | 43.88% | Truist证券 | $11 → $2 | 评级下调 | 购买→Hold |
| 04/01/2022 | 763.31% | Truist证券 | $15 → $12 | 维护 | 买 |
| 09/13/2021 | 151.8% | HC Wainwright公司 | → $3.5 | 开始承保 | →中性 |
| 09/02/2021 | — | 威廉·布莱尔 | 评级下调 | 跑赢→市场表现 | |
| 05/10/2021 | 403.6% | SVB Leerink | $8 → $7 | 维护 | 市场表现 |
| 03/23/2021 | 475.54% | SVB Leerink | $9 → $8 | 评级下调 | 跑赢→市场表现 |
| 11/06/2020 | 619.42% | 杰富瑞 | → $10 | 评级下调 | 购买→Hold |
| 10/19/2020 | 3856.83% | Truist证券 | → $55 | 开始承保 | →购买 |
| 07/08/2020 | 2633.81% | SVB Leerink | $36 → $38 | 维护 | 跑赢大盘 |
| 10/16/2019 | 1338.85% | 瑞穗 | → $20 | 开始承保 | →购买 |
| 10/08/2018 | 2921.58% | B.莱利证券 | $42 → $42 | 升级 | 中性→购买 |
| 08/08/2018 | 5223.74% | 贝尔德 | → $74 | 开始承保 | →跑赢大盘 |
| 05/08/2018 | 2921.58% | B.莱利证券 | $45 → $42 | 维护 | 中性 |
| 04/13/2018 | — | 查尔丹资本 | 评级下调 | 购买→中性 | |
| 01/05/2018 | 2417.99% | B.莱利证券 | → $35 | 开始承保 | →中性 |
What is the target price for Assembly Biosciences (ASMB)?
组装生物科学(ASMB)的目标价格是多少？
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by Mizuho on November 16, 2022. The analyst firm set a price target for $3.00 expecting ASMB to rise to within 12 months (a possible 115.83% upside). 3 analyst firms have reported ratings in the last year.
瑞穗于2022年11月16日报道了组装生物科学公司(纳斯达克代码：ASMB)的最新目标价。这家分析公司将目标价定为3美元，预计ASMB将在12个月内上涨至(可能上涨115.83%)。3家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Assembly Biosciences (ASMB)?
组装生物科学(ASMB)的最新分析师评级是多少？
The latest analyst rating for Assembly Biosciences (NASDAQ: ASMB) was provided by Mizuho, and Assembly Biosciences maintained their buy rating.
瑞穗对Assembly Biosciences(纳斯达克代码：ASMB)的最新分析师评级为买入，Assembly Biosciences维持买入评级。
When is the next analyst rating going to be posted or updated for Assembly Biosciences (ASMB)?
组装生物科学(ASMB)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Assembly Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Assembly Biosciences was filed on November 16, 2022 so you should expect the next rating to be made available sometime around November 16, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Assembly Biosciences的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。组装生物科学的最后一次评级是在2022年11月16日提交的，所以你应该预计下一次评级将在2023年11月16日左右的某个时候提供。
Is the Analyst Rating Assembly Biosciences (ASMB) correct?
分析师对组装生物科学(ASMB)的评级正确吗？
While ratings are subjective and will change, the latest Assembly Biosciences (ASMB) rating was a maintained with a price target of $14.00 to $3.00. The current price Assembly Biosciences (ASMB) is trading at is $1.39, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的组装生物科学(ASMB)评级保持不变，目标价在14.00美元至3.00美元之间。Assembly Biosciences(ASMB)目前的交易价格为1.39美元，超出了分析师的预测范围。